L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease

Kim Tieu, Celine Perier, Miquel Vila, Casper Caspersen, Hui-Ping Zhang, Peter Teismann, Vernice Jackson-Lewis, David M Stern, Shi Du Yan, Serge Przedborski

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD). Here, we report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alcohol dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice. We also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates. This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP production. This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.
Original languageEnglish
Pages (from-to)51-60
Number of pages10
JournalAnnals of Neurology
Volume56
Issue number1
Early online date28 Jun 2004
DOIs
Publication statusPublished - Jul 2004

Keywords

  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model
  • amyloid-beta-peptide
  • binding alochol-dehydrogenase
  • coenzyme-A dehydrogenase
  • mitochondrial complex-I
  • 3-hydroxyacyl-COA dehydrogenase
  • dopaminergic neurodegeneration
  • substantia-nigra
  • bovine liver
  • MPTP

Cite this

Tieu, K., Perier, C., Vila, M., Caspersen, C., Zhang, H-P., Teismann, P., ... Przedborski, S. (2004). L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. Annals of Neurology, 56(1), 51-60. https://doi.org/10.1002/ana.20133

L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. / Tieu, Kim; Perier, Celine; Vila, Miquel; Caspersen, Casper; Zhang, Hui-Ping; Teismann, Peter; Jackson-Lewis, Vernice; Stern, David M; Yan, Shi Du; Przedborski, Serge.

In: Annals of Neurology, Vol. 56, No. 1, 07.2004, p. 51-60.

Research output: Contribution to journalArticle

Tieu, K, Perier, C, Vila, M, Caspersen, C, Zhang, H-P, Teismann, P, Jackson-Lewis, V, Stern, DM, Yan, SD & Przedborski, S 2004, 'L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease', Annals of Neurology, vol. 56, no. 1, pp. 51-60. https://doi.org/10.1002/ana.20133
Tieu K, Perier C, Vila M, Caspersen C, Zhang H-P, Teismann P et al. L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. Annals of Neurology. 2004 Jul;56(1):51-60. https://doi.org/10.1002/ana.20133
Tieu, Kim ; Perier, Celine ; Vila, Miquel ; Caspersen, Casper ; Zhang, Hui-Ping ; Teismann, Peter ; Jackson-Lewis, Vernice ; Stern, David M ; Yan, Shi Du ; Przedborski, Serge. / L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease. In: Annals of Neurology. 2004 ; Vol. 56, No. 1. pp. 51-60.
@article{3913078e303d4200827f43b521074bc6,
title = "L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease",
abstract = "The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD). Here, we report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alcohol dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice. We also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates. This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP production. This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.",
keywords = "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model, amyloid-beta-peptide, binding alochol-dehydrogenase, coenzyme-A dehydrogenase, mitochondrial complex-I, 3-hydroxyacyl-COA dehydrogenase, dopaminergic neurodegeneration, substantia-nigra, bovine liver, MPTP",
author = "Kim Tieu and Celine Perier and Miquel Vila and Casper Caspersen and Hui-Ping Zhang and Peter Teismann and Vernice Jackson-Lewis and Stern, {David M} and Yan, {Shi Du} and Serge Przedborski",
year = "2004",
month = "7",
doi = "10.1002/ana.20133",
language = "English",
volume = "56",
pages = "51--60",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease

AU - Tieu, Kim

AU - Perier, Celine

AU - Vila, Miquel

AU - Caspersen, Casper

AU - Zhang, Hui-Ping

AU - Teismann, Peter

AU - Jackson-Lewis, Vernice

AU - Stern, David M

AU - Yan, Shi Du

AU - Przedborski, Serge

PY - 2004/7

Y1 - 2004/7

N2 - The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD). Here, we report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alcohol dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice. We also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates. This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP production. This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.

AB - The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD). Here, we report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alcohol dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice. We also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates. This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP production. This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.

KW - 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model

KW - amyloid-beta-peptide

KW - binding alochol-dehydrogenase

KW - coenzyme-A dehydrogenase

KW - mitochondrial complex-I

KW - 3-hydroxyacyl-COA dehydrogenase

KW - dopaminergic neurodegeneration

KW - substantia-nigra

KW - bovine liver

KW - MPTP

U2 - 10.1002/ana.20133

DO - 10.1002/ana.20133

M3 - Article

VL - 56

SP - 51

EP - 60

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 1

ER -